Oncology

Filter

Person receives treatment in hospital

Radioactive Drug Shows Promise as Prostate Cancer Treatment

2 Mins

August 2026

Lutetium-177 PSMA-617 cut the risk of prostate cancer progression or death by 28% when added to hormone therapy.

Person receives treatment in hospital

Radioactive Drug Shows Promise as Prostate Cancer Treatment

Lutetium-177 PSMA-617 cut the risk of prostate cancer progression or death by 28% when added to hormone therapy.

The role of biomarker testing in treatment decision making: Current and future perspectives

Prof Ahmad Awada is Head of Oncology Medicine Department at the Jules Bordet Institute, Brussels, Belgium, and specialises in the…

The Innovation, Care, and Compassion of Daiichi Sankyo – Part 2

In Part 2 below, we move onto the science being developed, and the innovations that have and are taking place.

The Innovation, Care, and Compassion of Daiichi Sankyo – Part 1

Daiichi Sankyo has, in a relatively short time-frame, become one of the most important pharmaceutical companies in the field of oncology….

An Interview with Robert Music, Chief Executive of Jo’s Cervical Cancer Trust

To coincide with this year’s Cervical Cancer Prevention Week, taking place from 22nd–28th January, the European Medical Journal was delighted to speak to…

An Interview with Victoria Thomas, Head of Public Involvement at NICE

The European Medical Journal caught up with Ms Victoria Thomas, who is Head of Public Involvement at the National Institute for Health and Care Excellence..

Loading posts...